Cargando…
EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
Autores principales: | ROY, ARCHANA, NAGA YARRARAPU, SIVA, NAZARENO, MARK, SANGHAVI, DEVANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503101/ http://dx.doi.org/10.1016/j.chest.2021.07.1013 |
Ejemplares similares
-
INHALED NITRIC OXIDE IN COVID-19-INDUCED HYPOXEMIC RESPIRATORY FAILURE
por: NAGA YARRARAPU, SIVA, et al.
Publicado: (2021) -
ELEVATIONS OF PROCALCITONIN AND D-DIMER IN PATIENTS WITH COVID-19 CORRELATE WITH VENTILATOR-ASSOCIATED PNEUMONIA IN THE SETTING OF VENTILATOR-ASSOCIATED EVENTS AND SPUTUM PRODUCTION
por: VAN, A., et al.
Publicado: (2022) -
CRYPTOGENIC ORGANIZING PNEUMONIA: A DIAGNOSTIC DILEMMA IN A WORLD DOMINATED BY COVID-19 PNEUMONIA
por: SAEED, HASHAM, et al.
Publicado: (2022) -
OSIMERTINIB PNEUMONITIS MASQUERADING AS COVID-19 PNEUMONIA
por: ALHALABI, ELIANE, et al.
Publicado: (2021) -
CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)